SP0014 THE LATEST NEWS ON BIOSIMILARS TREATMENT
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.8512
Abstract: Biologic medications have revolutionized the treatment of many rheumatologic diseases, but their high cost often limits patient access to these effective treatments. Biosimilars are legitimate copies of biopharmaceuticals, which no longer are protected by patent,… read more here.
Keywords: reference; treatment; cost; biologic medications ... See more keywords
The Current Role for Biologic Medications in the Treatment of Pediatric COVID-19 and MIS-C.
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric annals"
DOI: 10.3928/19382359-20220114-01
Abstract: Severe cases of coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) are characterized by hyperinflammation and multiorgan dysfunction. Although the incidence and mortality of these illnesses are low in the pediatric population,… read more here.
Keywords: current role; treatment; covid mis; biologic medications ... See more keywords